MINERAL METABOLISM IN TURNERS SYNDROME - EVIDENCE FOR IMPAIRED RENAL VITAMIN-D METABOLISM AND NORMAL OSTEOBLAST FUNCTION

被引:19
作者
SAGGESE, G
FEDERICO, G
BERTELLONI, S
BARONCELLI, GI
机构
关键词
D O I
10.1210/jc.75.4.998
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We examined intact PTH and 1,25-dihydroxyvitamin D [1,25-(OH)2D] in both baseline and dynamic conditions (low calcium diet) in 14 patients with Turner's syndrome (mean age, 12.6 +/- 5.9 yr; range, 4.2-21.0 yr) and bone demineralization as well as in a control group of 15 healthy girls (mean age, 12.8 +/- 5.6 yr; range, 3.8-22.7 yr). In both groups we also measured osteocalcin serum levels in response to oral 1,25-(OH)2D3 administration (1.8 mug/m2/daily for 6 days) to assess osteoblast function. The low calcium diet decreased ionized calcium (Ca2+) levels and elevated PTH values to the same extent in both patients (Ca2+, -8.40 +/- 3.78%; intact PTH, +47.88 +/- 13.24%) and controls (Ca2+, -9.09 +/- 3.25%; intact PTH, +52.77 +/- 10.52%; P = NS vs. patients). While controls showed an increment in their serum 1,25-(OH)2D levels (+52.15 +/- 8.95%), patients did not (+10.93 +/- 4.71%; P = NS vs. baseline; P < 0.001 vs. controls). 1,25-(OH)2D3 administration caused a rise in the serum osteocalcin levels in a similar fashion in both groups (peak values: patients, +35.38 +/- 7.20%; controls, +34.09 +/- 7.98%; P = NS). We conclude that in patients with Turner's syndrome there is an altered renal vitamin D metabolism in response to physiological stimulus, while osteoblast function in response to 1,25-(OH)2D3 administration is not affected.
引用
收藏
页码:998 / 1001
页数:4
相关论文
共 32 条
[1]   HEPARIN-INDUCED INHIBITION OF 1,25-DIHYDROXYVITAMIN-D FORMATION [J].
AARSKOG, D ;
AKSNES, L ;
MARKESTAD, T ;
ULSTEIN, M ;
SAGEN, N .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1984, 148 (08) :1141-1142
[2]  
BERCU BB, 1976, PEDIATRICS, V58, P737
[3]   OSTEOPOROSIS IN OVARIAN DYSGENESIS [J].
BROWN, DM ;
JOWSEY, J ;
BRADFORD, DS .
JOURNAL OF PEDIATRICS, 1974, 84 (06) :816-820
[4]   THE HORMONAL FORM OF VITAMIN-D IN THE PATHO-PHYSIOLOGY AND THERAPY OF POSTMENOPAUSAL OSTEOPOROSIS [J].
CANIGGIA, A ;
NUTI, R ;
LORE, F ;
VATTIMO, A .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1984, 7 (04) :373-378
[5]   EFFECTS OF LOW-CALCIUM DIET ON URINE CALCIUM EXCRETION, PARATHYROID FUNCTION AND SERUM 1,25(OH)2D3 LEVELS IN PATIENTS WITH IDIOPATHIC HYPERCALCIURIA AND IN NORMAL SUBJECTS [J].
COE, FL ;
FAVUS, MJ ;
CROCKETT, T ;
STRAUSS, AL ;
PARKS, JH ;
PORAT, A ;
GANTT, CL ;
SHERWOOD, LM .
AMERICAN JOURNAL OF MEDICINE, 1982, 72 (01) :25-32
[6]   SERUM OSTEOCALCIN CONCENTRATIONS IN CHILDREN WITH METABOLIC BONE-DISEASE [J].
COLE, DEC ;
CARPENTER, TO ;
GUNDBERG, CM .
JOURNAL OF PEDIATRICS, 1985, 106 (05) :770-776
[7]   1,25-DIHYDROXYVITAMIN-D STIMULATION TEST FOR OSTEOBLAST FUNCTION IN NORMAL AND OSTEOPOROTIC POSTMENOPAUSAL WOMEN [J].
DUDA, RJ ;
KUMAR, R ;
NELSON, KI ;
ZINSMEISTER, AR ;
MANN, KG ;
RIGGS, BL .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 79 (04) :1249-1253
[8]   EVIDENCE THAT SOMATOMEDINS MEDIATE THE EFFECT OF HYPOPHOSPHATEMIA TO INCREASE SERUM 1,25-DIHYDROXYVITAMIN D3 LEVELS IN RATS [J].
GRAY, RW .
ENDOCRINOLOGY, 1987, 121 (02) :504-512
[9]   PERMISSIVE ACTION OF GROWTH-HORMONE ON THE RENAL RESPONSE TO DIETARY PHOSPHORUS DEPRIVATION [J].
HARBISON, MD ;
GERTNER, JM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 70 (04) :1035-1040
[10]   CHANGES IN VITAMIN-D METABOLISM DURING NATURAL AND MEDICAL MENOPAUSE [J].
HARTWELL, D ;
RIIS, BJ ;
CHRISTIANSEN, C .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 71 (01) :127-132